Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001365341 | SCV001561607 | benign | Amyotrophic lateral sclerosis type 4; Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002404871 | SCV002669486 | likely benign | Inborn genetic diseases | 2021-05-24 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV003128783 | SCV003806229 | uncertain significance | not provided | 2022-08-17 | criteria provided, single submitter | clinical testing | Identified in two patients with adult-onset ALS, one of whom also harbored a variant in the ALS2 gene (Kenna et al., 2013); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 28413711, Kitao R. 2020, 23881933) |
Revvity Omics, |
RCV003128783 | SCV003827513 | uncertain significance | not provided | 2020-12-11 | criteria provided, single submitter | clinical testing |